TAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTDTAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD

No trades
See on Supercharts

Price target

4,701.910.000.00%
The 13 analysts offering 1 year price forecasts for 4502 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to 4502 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


4502 EPS for the last quarter is 58.21 JPY despite the estimation of 37.05 JPY. In the next quarter EPS is expected to reach 32.82 JPY. Track more of TAKEDA PHARMACEUTICAL CO LTD financials and stay on top of what is up with the company.
In the next quarter TAKEDA PHARMACEUTICAL CO LTD revenue is expected to reach ‪1.17 T‬ JPY. Check out TAKEDA PHARMACEUTICAL CO LTD revenue and earnings and make informed decisions.
According to analysts, 4502 price target is 4,701.91 JPY with a max estimate of 5,900.00 JPY and a min estimate of 4,200.00 JPY. Check if this forecast comes true in a year, meanwhile watch TAKEDA PHARMACEUTICAL CO LTD stock price chart and keep track of the current situation with 4502 news and stock market news.
We've gathered opinions of 15 analysts rating 4502 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.